CD34-selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed, High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2015.07.577
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2015
Authors
Publisher
Elsevier BV